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The Comment1 (published July 27, 
2019) by Maxwell and Webb on 
prescribing safety assessment 
rightfully highlights the central role of 
education and training to improving 
the safe delivery of medicines.
In 2017, the WHO’s Global Patient 
Safety Challenge identified three key 
action areas (polypharmacy, high-risk 
situations, and transitions of care) to 
reduce severe and avoidable 
medication-related harm.2 To 
successfully achieve this objective, we 
believe that the combined work of 
clinical pharmacists and physicians is 
essential in each of these areas and 
should occur at every stage of the 
patient care pathway, including 
hospitalisation and transitions of care, 
as they are both high risk periods for 
medication mistakes.3 Given the 
complexity of the prescribing process 
and considering the frequent 
workflow interruptions and stress 
sources for prescribers in daily practice, 
the implementation of physician 
learning programmes might be 
warranted, but not sufficient, to 
guarantee the safe and effective use of 
medicines. The combined intervention 
of clinical pharmacists and physicians 
within a collaborative medication 
reconciliation process has a high 
potential for reducing downstream 
clinical errors and could be efficient in 
all WHO action areas described 
above.2,3
Further, even if studies proved 
medication reconciliation to be 
efficient to reduce medication errors, 
its effect on hard patient outcomes, 
such as adverse drug events and 
hospital readmissions, are debated 
and controversial.3,4 A multicentre, 
prospective study (NCT04018781) 
associated with qualitative research 
methods that explore the 
organisational, clinical, and economic 
effects of medication reconciliation, 
especially for older patients after 
hospital discharge, could help to 
highlight the strength of this 
collaboration of clinical pharmacists 
with physicians for prescribing safety.5 
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